ICM
GSK icon

IMS Capital Management’s GSK GSK Stock Holding History

IMS Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-130
Closed -$7K – 219
2018
Q3 		$7K Buy
+130
New +$6.61K ﹤0.01% 334
2014
Q1 		– Sell
-3,332
Closed -$222K – 166
2013
Q4 		$222K Buy
+3,332
New +$216K 0.28% 114

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

IMS Capital Management's GSK Position: Q4 2018 in Review

IMS Capital Management sold out of GSK (GSK) in Q4 2018, closing a stake of 130 shares — an estimated $7K sold.

IMS Capital Management first reported a position in GSK in Q4 2013 and held it in 2 quarters. The position peaked at $222K in Q4 2013. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • IMS Capital Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • IMS Capital Management sold 130 GSK shares in Q4 2018, an estimated $7K.
  • IMS Capital Management first reported a position in GSK in Q4 2013 and held it in 2 quarters.
  • IMS Capital Management's GSK position peaked at $222K in Q4 2013.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on IMS Capital Management's 13F filing for Q4 2018, filed 7 Feb 2019.